Table 1 Baseline characteristics of the study subjects.
Number (%) | Overall | Pre-pandemic (2017.1 -2020.1) | Pandemic (2020.2-2021.6) | p-value | |
|---|---|---|---|---|---|
Sex | male | 814,506 (50.95%) | 533,948 (51.71%) | 280,558 (49.57%) | < 0.001 |
female | 784,034 (49.05%) | 498,580 (48.29%) | 285,454 (50.43%) | ||
Age at diagnosis | 20–29 | 400,467 (25.05%) | 247,224 (23.94%) | 153,243 (27.07%) | < 0.001 |
30–39 | 321,769 (20.13%) | 210,030 (20.34%) | 111,739 (19.74%) | ||
40–49 | 308,549 (19.30%) | 205,819 (19.93%) | 102,730 (18.15%) | ||
50–59 | 276,819 (17.32%) | 184,222 (17.84%) | 92,597 (16.36%) | ||
60–69 | 173,830 (10.87%) | 110,530 (10.71%) | 63,300 (11.18%) | ||
70–79 | 83,290 (5.21%) | 53,564 (5.19%) | 29,726 (5.25%) | ||
80- | 33,816 (2.12%) | 21,139 (2.05%) | 12,677 (2.24%) | ||
Type of insurance | National Health Insurance | 1,548,897 (96.89%) | 1,000,022 (96.85%) | 548,875 (96.97%) | < 0.001 |
Medical aid | 49,643 (3.11%) | 32,506 (3.15%) | 17,137 (3.03%) | ||
Total | 1,598,540 (100%) | 1,032,528 (100%) | 566,012 (100%) |
